Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the Time To Disease Progression (TTDP) between those
patients with unresectable, locally recurrent or metastatic breast cancer who are treated
with concomitant Docetaxel plus Gemcitabine to those patients treated with sequential therapy
of Docetaxel followed by Gemcitabine.